患者教育在骨质疏松预防中的作用:一项聚焦随机对照试验方法学质量的系统评价
该系统评价检索多个数据库至2016年2月,纳入15篇文章(13项研究),评估患者教育对骨质疏松预防和治疗的效果。结果显示,在骨密度检测和/或药物治疗(复合终点)、钙摄入、维生素D摄入及骨质疏松知识方面,至少50%分析这些结局的研究支持干预组有统计学显著获益;而在药物治疗、用药依从性、体力活动、骨折和生活质量方面,支持干预组有统计学显著差异的研究不足50%。结论指出患者教育是否对骨质疏松管理有益仍不明确,需要进一步在高质量随机对照试验中研究。
要点
- 在至少50%分析骨密度检测和/或药物治疗(复合终点)、钙摄入、维生素D摄入及骨质疏松知识的研究中,干预组有统计学显著获益。
- 在不足50%的试验中,药物治疗、用药依从性、体力活动、骨折和生活质量方面干预组与对照组差异有统计学显著意义。
- 总体偏倚风险为中到高,患者教育对骨质疏松管理的获益仍不明确,需进一步在高质量随机对照试验中研究。
核心结论
- 该系统评价表明,患者教育是否对骨质疏松管理结果有益、是否具有显著且临床相关的影响仍不明确。
- 骨质疏松教育项目需在实施良好的随机对照试验中进一步研究。
研究设计与样本
- 系统评价检索PubMed和Embase等多个数据库,检索截至2016年2月。
- 纳入标准为包含诊断为骨质疏松或有骨质疏松风险的成人、评估患者教育干预(基于小组或基于个体)的随机对照试验。
- 共纳入2001年至2013年间发表的15篇文章(13项不同研究),其中基于小组的教育7项、基于个体的教育5项、两者兼有1项。
- 采用Cochrane协作组的偏倚风险评估工具评估纳入试验的内部真实性。
主要发现
- 在至少50%分析骨密度检测和/或药物治疗(复合终点)、钙摄入、维生素D摄入及骨质疏松知识的研究中,干预组有统计学显著获益。
- 在不足50%的试验中,药物治疗、用药依从性、体力活动、骨折和生活质量方面干预组与对照组差异有统计学显著意义。
- 总体偏倚风险被认为中到高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 总体偏倚风险为中到高。
- 患者教育是否对骨质疏松管理结果有益仍不明确,需在实施良好的随机对照试验中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This review summarizes evidence regarding the effects of patient education in osteoporosis prevention and treatment. The included studies reveal mixed results on a variety of endpoints. Methodological improvem ent of future RCTs (e.g. with regard to randomization and duration of follow-up) might yield more conclusive evidence on the effects of patient education in osteoporosis INTRODUCTION: This review aims to evaluate the effects of patient education on osteoporosis prevention and treatment results. METHODS: Multiple databases including PubMed and Embase were searched until February 2016. Randomised controlled trials (RCTs) were eligible if they included adults diagnosed with or at risk of osteoporosis and assessed patient education interventions (group- or individual-based). Outcomes regarding osteoporosis management including initiation of and adherence to pharmacological therapy, physical activity, calcium and vitamin D intake, changes in smoking behaviour, fractures, quality of life (QoL) and osteoporosis knowledge were evaluated. The Cochrane collaboration's tool for assessing the risk of bias was used to assess the internal validity of included trials. RESULTS: Fifteen articles (13 different studies) published between 2001 and 2013 were included (group-based education = 7, individual-based education = 5, both = 1). The general risk of bias was considered as moderate to high. The effects on 'bone mineral density (BMD) testing and/or pharmacological therapy' (composite endpoint), 'calcium intake' and 'vitamin D intake' as well as 'osteoporosis knowledge' were statistically significant in favour of the intervention in ≥50% of the studies analysing these outcomes. Differences between the intervention and the control group regarding 'pharmacological therapy', 'medication adherence', 'physical activity', 'fractures' and 'QoL' were found to be statistically significant in <50% of the trials. CONCLUSIONS: This review indicates that it is still unclear whether patient education is beneficial and whether it has a significant and clinically relevant impact on osteoporosis management results. Educational programmes for osteoporosis require further investigation within the context of well-conducted RCTs.
引用
- Morfeld JC, Vennedey V, Müller D, et al. Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials. Osteoporos Int. 2017. PMID: 28236127. doi:10.1007/s00198-017-3946-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。